Not applicableUnknownNCT05486988What this trial is testingCtDNA as a Biomarker for Treatment in Advanced NSCLCWho this might be right forNon-small Cell Lung Cancer Fuzhou General Hospital 500
Testing effectiveness (Phase 2)Study completedNCT00589056What this trial is testingNelfinavir, Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By SurgeryWho this might be right forLung Cancer Abramson Cancer Center at Penn Medicine 55
Early research (Phase 1)Study completedNCT03590054What this trial is testingAbexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor MalignanciesWho this might be right forStage III Cutaneous MelanomaStage IV Cutaneous MelanomaLocally Advanced Melanoma+18 more Rahul Aggarwal 35
Testing effectiveness (Phase 2)Study completedNCT00022646What this trial is testingPemetrexed Disodium Plus Gemcitabine in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerWho this might be right forLung Cancer Alliance for Clinical Trials in Oncology 157
Testing effectiveness (Phase 2)Study completedNCT00094861What this trial is testingStudy to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC)Who this might be right forDysphagiaNon-Small Cell Lung CancerLung Cancer Swedish Orphan Biovitrum 100
Testing effectiveness (Phase 2)UnknownNCT00083083What this trial is testingFludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung CancerWho this might be right forLung Cancer American College of Radiology Imaging Network 250
Large-scale testing (Phase 3)UnknownNCT03074864What this trial is testingTargeted Treatment With Intercalated Radiotherapy in EGFR-mutant IIIA/IIIB NSCLCWho this might be right forNon-small Cell Lung CancerEpidermal Growth Factor Receptor Guangdong Provincial People's Hospital 90
Large-scale testing (Phase 3)Looking for participantsNCT06617416What this trial is testingAK104 in Subjects With Unresectable Locally Advanced NSCLCWho this might be right forNSCLC (Non-small Cell Lung Cancer) Akeso 560
Early research (Phase 1)Active Not RecruitingNCT03893955What this trial is testingDetermine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid TumorsWho this might be right forCancerAdvanced Solid TumorsTriple-Negative Breast Cancer (TNBC)+2 more AbbVie 150
Early research (Phase 1)Ended earlyNCT03809624What this trial is testingStudy of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck CancerWho this might be right forMetastatic Solid TumorsNon-small Cell Lung CancerMelanoma+6 more Inhibrx Biosciences, Inc 160
Testing effectiveness (Phase 2)Study completedNCT00918203What this trial is testingPaclitaxel/Carboplatin With or Without Olaratumab (IMC-3G3) in Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)Who this might be right forNon-Small Cell Lung Cancer Eli Lilly and Company 137
Testing effectiveness (Phase 2)Looking for participantsNCT07164170What this trial is testingClinical Study of Combination Therapy With ABSK043 and GlecirasibWho this might be right forNon-Small Cell Lung Cancer Abbisko Therapeutics Co, Ltd 86
Not applicableActive Not RecruitingNCT06277388What this trial is testingEvaluation of Impedance Cardiography for Assessing Hemodynamic Shifts in Patients With LA-NSCLC During Treatment.Who this might be right forNon-small Cell Lung CancerCardiac Toxicity Sun Yat-sen University 231
Post-approval studies (Phase 4)UnknownNCT04814056What this trial is testingTo Evaluate the Efficacy of Afatinib in the Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer With NRG1 FusionWho this might be right forNRG1-fused Non-small Cell Lung Cancer Shanghai Chest Hospital 15
Testing effectiveness (Phase 2)UnknownNCT05552781What this trial is testingH002 in Patients With EGFR Mutation Locally Advanced or Metastatic NSCLCWho this might be right forNon-small Cell Lung Cancer RedCloud Bio 76
Testing effectiveness (Phase 2)Study completedNCT03679767What this trial is testingINCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)Who this might be right forMetastatic Non-small Cell Lung CancerLocally Advanced Urothelial CancerMetastatic Urothelial Cancer+4 more Incyte Corporation 121
Early research (Phase 1)Study completedNCT00496275What this trial is testingPhase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLCWho this might be right forNon Small Cell Lung Cancer Genzyme, a Sanofi Company 17
Early research (Phase 1)Study completedNCT02014337What this trial is testingMifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid TumorsWho this might be right forBreast CancerOvarian Epithelial Cancer RecurrentSarcoma+4 more Corcept Therapeutics 37
Early research (Phase 1)Looking for participantsNCT07056556What this trial is testingBL-M09D1 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer and Other Solid TumorsWho this might be right forNon-small Cell Lung CancerSolid Tumor Sichuan Baili Pharmaceutical Co., Ltd. 31
Large-scale testing (Phase 3)Looking for participantsNCT06980272What this trial is testingSSGJ-707 in Advanced Non-Small Cell Lung CancerWho this might be right forAdvanced Non-Small Cell Lung Cancer Shenyang Sunshine Pharmaceutical Co., LTD. 420